15 research outputs found
Number of screen-detected cases by age group for stomach and colorectal cancer in the CanReCO project, Osaka, Japan, 2019 and 2020.
(PDF)</p
Baseline characteristics of patients diagnosed with six digestive cancers in the CanReCO project.
Baseline characteristics of patients diagnosed with six digestive cancers in the CanReCO project.</p
Treatment patterns and pathological stage in patients with six digestive cancers in the CanReCO project.
Treatment patterns and pathological stage in patients with six digestive cancers in the CanReCO project.</p
Number of operations and median time to operation for six digestive cancers.
Bar graphs indicate number of operations (left axis: blue 2019, pink 2020) and line graphs indicate monthly median time in days from diagnosis to operation (right axis: blue dash 2019, red solid 2020). Note that both the right and left axes are different for stomach and colorectal cancer.</p
Number of endoscopic surgeries and median time to endoscopic surgery by month for three digestive cancers in the CanReCO project, Osaka, Japan, 2019 and 2020.
(PDF)</p
Number of operations and median time to operation by month for six digestive cancers in the CanReCO project, Osaka, Japan, 2019 and 2020.
(PDF)</p
Number of diagnoses in 2019 and relative change in 2020 (reference: 2019) by cancer site in the CanReCO project, Osaka, Japan.
(PDF)</p
Number of endoscopic surgeries and median time to endoscopic surgery for stomach, colorectal and esophageal cancer.
Bar graphs indicate number of endoscopic surgeries (left axis: blue 2019, pink 2020) and line graphs indicate monthly median time in days from diagnosis to endoscopic surgery (right axis: blue dash 2019, red solid 2020).</p
Number of treatments and median time from diagnosis to first treatment by month of diagnosis for six digestive cancers in the CanReCO project, Osaka, Japan, 2019 and 2020.
(PDF)</p
Flow chart of eligible records with six digestive cancers in the CanReCO project.
Flow chart of eligible records with six digestive cancers in the CanReCO project.</p